CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 321 enrolled
Drug / intervention
MSK-Trackerother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03559205
NCT03559205N/ACompleted

Implementing the MSK-HQ to Empower Patients and Improve Services

Keele University·interventional·Posted Jun 18, 2018·Updated Nov 10, 2021

In Brief

A clinical study evaluating MSK-Tracker for Musculoskeletal Pain. Completed, enrolled 321 participants across 1 site.

Detailed Summary

This study will co-design and test the feasibility and impact of implementing the Arthritis Research UK Musculoskeletal Health Questionnaire (MSK-HQ) using an e-PROM (electronic Patient Reported Outcome Measure) delivered via a digital health platform, with innovative embedded components called the MSK-Tracker. The MSK-Tracker uses the MSK-HQ as a foundation to help patients with MSK pain to: * track the extent to which they are affected by their MSK condition across different aspects of their health, * prepare appropriately for their clinical encounters, and * take the right steps to making positive changes to improve their quality of life and manage their condition over the longer-term. The Study Aims to: 1. Test the ability of the MSK-Tracker to act as an empowerment tool and method of facilitating a person-centred care planning approach in routine MSK clinic consultations. 2. Assess the value of the MSK-Tracker in generating aggregated outputs that inform MSK service improvement. Study Design This study will use a before and after single Centre design with the comparator between phases 1 and 3 across a range of outcomes. Phase 2 will focus on iterative testing of the MSK-Tracker. In addition, in Phase 1 and 3 will include qualitative research (site 1 only) using the Experience Based Co-Design (EBCD) methodology to explore the impact of the MSK-Tracker and to inform further improvement and refinement of the tool and its use within the context of an MSK service and clinical practice. The findings from the qualitative research will be triangulated with insights from the aggregated data of patient outcomes to enrich and help make sense of the study findings.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 18, 2018
Enrollment StartJul 10, 2018
Primary CompletionJun 30, 2019
Study CompletionDec 30, 2019
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 8.0 years ago

Interventions

MSK-Trackerother

The intervention is not a treatment, but involves patients and clinicians engaging with the MSK-Tracker software which will facilitate a new care planning approach with the following distinct components: * Pre-clinic preparation. * Clinic dashboard. * Summary action plan. * Personal goal setting. * Follow-up and monitoring.